AstraZeneca partners with Lion on cancer drugs; Broad's Singer joins Rodin board;

@FierceBiotech: As trouble mounts, a chastened Martin Shkreli says bad boy persona was just an 'experiment.' Article | Follow @FierceBiotech

@JohnCFierce: Boehringer grabs 'breakthrough,' plots pivotal trials for rival to AstraZeneca, Clovis. (What breakthrough?) More | Follow @JohnCFierce

> AstraZeneca ($AZN) subsidiary MedImmune will collaborate with Lion Biotechnologies ($LBIO) that will pair the pharma giant's PD-L1 checkpoint inhibitor durvalumab with the biotech's tumor-infiltrating lymphocytes. Release

> Cambridge, MA-based Rodin Therapeutics named Samantha Singer, the COO of the Broad Institute of MIT and Harvard, to their board. Release

Medical Device News

@FierceMedDev: ICYMI yesterday: Philips' Volcano to keep Sacramento site despite 60 manufacturing layoffs. Article | Follow @FierceMedDev

@EmilyWFierce: Hey doc, what's on the menu when pharma comes calling? Hint: It's not health food. Story from FiercePharmaMarketing | Follow @EmilyWFierce

> DOJ settles with 32 hospitals for $105M over improper Medicare billing related to spinal surgery. Article

> Regulators probe complaints from former Theranos employees over lab, testing practices: WSJ. More

Pharma News

@FiercePharma: Gene-testing business boosts Neogen's sales but earnings fall short of high expectations. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: WuXi clarifies just what AstraZeneca is buying, or actually what it isn't buying. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: ICYMI Friday: GSK adds Bristol-Myers pipeline drugs to challenge Gilead in HIV. Article | Follow @CarlyHFierce

> Medicaid would have saved $1.4B with discounts for generics: Report. Story

> Ready to step up M&A, Bayer could target big game like Pfizer's OTC unit, Zoetis. Report

Pharma Marketing News

> New FDA policy gives its staff wide latitude on social media. Could pharma freedom follow? More

> Hey doc, what's on the menu when pharma comes calling? Hint: It's not health food. Story

> Bayer, coveting top spots in animal and consumer health, may eye deals for Zoetis, Pfizer OTC. Item

> Headaches for Reckitt over charges of misleading claims for OTC painkillers. Article

Animal Health News

> Sanofi, Boehringer to create new animal health giant in $12.5B asset swap. News

> U.S. states lift bird-flu bans and quarantines as reports of virus mount overseas. Article

> Jaguar shares jump on string of positive news in equine health. Report

> AB Science's Kinavet cancer drug for dogs loses FDA marketing authorization. Item

> Toxin from sea algae impacts memory, behavior in California sea lions: Study. More

Biotech IT News

> Shkreli's Twitter account hacked, spokesperson says. Item

> UCB taps Congenica tech for help with target discovery. News

> MorphoSys picks Dotmatics tool to visualize, analyze screening data. Report

> FDA hits tight timeline for start of precisionFDA open beta. More

> FDA CTO admits security shortcomings are holding back data sharing. Article

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

Janssen is tapping little-known and privately held Hemera Biosciences for a new gene therapy aimed at reversing a severe disease.

Harvard scientists showed that a three-gene cocktail, by epigenetic reprogramming, could reverse the aging clock in mice retina nerve cells.

Merck is clearly still buzzing about its two-year Dragonfly Therapeutics pact, as it has snapped up a cancer program.